John Cox - 25 Mar 2024 Form 3/A Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
CEO & President, Director
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Issuer symbol
DYN
Transactions as of
25 Mar 2024
Net transactions value
$0
Form type
3/A
Filing time
04 Apr 2024, 21:07:38 UTC
Date Of Original Report
27 Mar 2024
Previous filing
11 Aug 2023
Next filing
04 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DYN Common Stock 5,000 25 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on March 27, 2024, which inadvertently reported 10,000 shares of common stock beneficially owned by the reporting person instead of the 5,000 shares reported herein.